Prognosis
Moderna Says Foreign Manufacturing Partners Facing Delays
- Problem has been resolved, but it has slowed release of shots
- Moderna says shipping shots as it makes them, no extra on hand
This article is for subscribers only.
Moderna Inc. said its Covid-19 vaccine manufacturing partners outside the U.S. are “facing delays” due to laboratory testing issues that occurred in recent days.
While the problem has been resolved, it has slowed release of Moderna’s vaccine to markets outside the U.S., a company spokeswoman said in an email.